Simmary First-and second-degree relatives of an unselected series of 402 breast cancer patients have been studied for their cancer experience. In the first-degree relatives an excess of all cancers is seen [overall relative risk (RR) = 1.28, P = 0002; males RR = 1.26, P = 0.047; females RR = 1.30, P= 0.022). There is a marked excess of sarcoma (RR = 4.26, P = 0.0064); females are at high risk of breast cancer (RR = 2.68, P<0.0001) and males have an excess of carcinoma of the lip, oral cavity and pharynx (RR = 4.22, P =0.0032). Second-degree relatives have a non-significant excess of all cancers (RR = 1. 14, P = 0. 14); females have a borderline excess of breast cancer (RR = 1.53, P = 0.08) and an excess of carcinoma of the kidney (RR = 7.46, P= 0.0012) and males have an excess of carcinoma of the trachea and lung (RR = 1.50, P = 0.032). Ltd., 1994 Br.
Breast cancer is the most common cancer in females, accounting for approximately 18% of all cancer in women worldwide (Parkin et al., 1988) . One of the strongest and most consistently found risk factors for breast cancer is a family history of the disease. Previous studies have compared breast cancer patients with a family history with those without, and found that the familial cases frequently have an early age at onset and often suffer from bilateral disease (Anderson, 1971 (Anderson, , 1974 Anderson & Badzioch, 1985) .
Segregation analyses of series of breast cancer patients and their families have indicated that a proportion of breast cancer may be due to inherited factors (Williams & Anderson, 1984; Newman et al., 1988; Claus et al., 1991) . The majority of segregation analyses have found that familial breast cancer can best be explained by a rare dominant major gene with high penetrance, but other studies have found that, although this explains some of the clustering, different models fit different groups of families (Andrieu et al., 1989) . Hall et al. (1990) found evidence for linkage of early-onset familial breast cancer to a marker on chromosome 17q21. Subsequent analyses of a large number of families have defined more precisely the position of this gene (Hall et al., 1992; Easton et al., 1993) . Easton et al. (1993) found that, in a series of 214 breast cancer families, all those which included at least one case of ovarian cancer were consistent with linkage to 17q21, while only 45% of families without were tightly linked. They also found that the families which demonstrated linkage to this region were those with many cases of breast cancer, and most cases within linked families were diagnosed at a young age. A higher proportion of the families with average age at diagnosis under 45 years appeared to be linked, with the proportion becoming smaller as the average age at onset rises. The families included in these linkage analyses were highly selected on the basis of their striking family histories, and the relevance of the 17q gene to breast cancer in general is not known. More general studies of risks to relatives have concentrated on young probands and breast cancer risks only. However, two recent reports have found an excess of cancers of the prostate, ovary, endometrium and cervix in the relatives of breast cancer probands (Anderson et al., 1992; Tulinius et al., 1992) . The present study was designed to assess the incidence of breast and other cancers, particularly prostate and ovary, in the relatives of an unselected series of breast cancer (Nwene & Smith, 1982 Observed numbers of cancer were compared with the expected, and a two-sided Poisson probability calculated. Relative risk ratios are estimated by dividing observed by expected numbers of cancers, and 95% confidence intervals calculated. All statistical analysis was done using Epilog Plus, version 2 (1987 For all cancers the relative risk in first-degree relatives is raised for all ages of index patient at diagnosis, but the risk is markedly higher in relatives of patients diagnosed in the age range 40-49. This age effect is also demonstrated in the second-degree relatives.
We have found no evidence that relatives of women diagnosed with bilateral breast cancer are at increased risk of breast cancer or cancer in general compared with relatives of those women with unilateral breast cancer. This could be because of the small number of patients with bilateral disease, but other studies have found bilaterality not to be a risk factor (Adami et al., 1981; Claus et al., 1990) . It may also have been due, in part, to our rigid definition of a bilateral breast cancer patient. However, the status of 'bilateral' can only be a retrospective one. Some of the women who were unilateral when eligible for our study may subsequently develop another primary breast cancer. The long term follow-up of these women and their relatives may ultimately resolve this matter.
Tulinius et al. (1992) found an excess of prostate, endometnal and ovarian cancer in the relatives of women with breast cancer. They had specifically examined these sites, and the risks of cancers of other sites and histological groups were not reported. Arason et al. (1993) (1992) . Our study, therefore, lacks the power to confirm, or refute, a relative risk of this magnitude, and it may be that in a small number of families these cancers do tend to cluster as a result of common aetiological factors.
There is an established excess risk of breast cancer for the mothers of children with a sarcoma (Li et al., 1969; Birch et al., 1984 Birch et al., , 1990 Strong et al., 1987) . Buirki et al. (1987) found an excess of sarcomas in the brothers of breast cancer patients. Familial aggregations of sarcoma, breast cancer and other neoplasms at young ages is referred to as the LiFraumeni syndrome. The excess of sarcoma seen in relatives of women with breast cancer in the present series is compatible with these previous observations. Recently, mutations in the tumour-suppressor gene, p53, have been found in some individuals whose families exhibit the Li-Fraumeni syndrome (Malkin et al., 1990; Santibifiez-Koref et al., 1991) . Among the second-degree relatives of our patients there were two children with neuroblastomas. It has recently been reported that a germlne p53 mutation has been found in a patient diagnosed with a neuroblastoma at age 1 year who subsequently developed breast cancer at age 32 years. Her mother also had breast cancer . Furthermore, among series of breast cancer patients examined for p53 germlne mutations, four examples have been found, all associated with a family history of breast and other cancers (B0rreson et al., 1992; Prosser et al., 1992; Sidransky et al., 1992) . This is further evidence for breast cancer being a heterogeneous disease, and the 'Li-Fraumeni' component 12-13 tests to be significant at the 5% level and 2-3 to be significant at the 1% level, and these results would be due to chance alone. In our analysis we see considerably more than this, so although some of our significant results may be due to chance, they are not simply an artifact of repeated testing.
Recent developments in breast cancer linkage studies have demonstrated strong evidence of tight linkage to the region 17q21 (Hall et al., 1990) . The families that appeared to be linked to this site were large, with predominantly early age at onset. Easton et al. (1993) Some families from our series were examined for linkage to 17q21, but the results were inconclusive (Teare et al., 1993) . The study by Skolnick et al. (1990) found evidence for a common breast cancer gene, with low penetrance, responsible for a considerable proportion of breast cancer. This is in contrast to the majority of segregation analyses, which have found familial clustering best described by a dominant rare gene with high penetrance (Newman et al., 1988; Claus et al., 1992; Iselius et al., 1992) .
The present study has found that relatives of breast cancer patients are at a higher risk of a variety of neoplasms than the general population. This excess of cancers, including breast cancer, is not limited to a small number of high-risk familie but appears to be spread across many. Given the evidence for genetic heterogeneity which has now come to light convincingly through linkage analyses, the various different single-gene models found by segregation analysis to 'best fit' familial breast cancer could be explained by ascertainment bias, with each analysis correctly modelling the data collected. Breast 
